Symbol
| ARHGAP26
| contributors: mct - updated : 23-05-2015
|
HGNC name
| Rho GTPase activating protein 26
|
HGNC id
| 17073
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
| fusion
| translocation
|  
|  
|
fusion with MLL in t(5;11)(q31;q23) in myelodysplastic syndrome | tumoral
|  
| deletion
|  
|  
|
deletion in myelodysplastic syndrome | tumoral
|  
|  
|  
| gain of function
|
activated in malignant melanoma | tumoral
|  
|  
| --low
|  
|
in myeloid malignancies  | constitutional
|  
|  
| --low
|  
|
decreased in ATRX patients  | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
| | | |
| GrafF1-depleted embryos exhibited elevated RhoA activity and defective myofibrillogenesis that resulted in progressive muscle degeneration, defective motility, and embryonic lethality  |